Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer Patients. A Randomised, Double-blind, Controlled Pilot Study

NCT00851448 is registered in ClinicalTrials.gov with Fresenius Kabi as lead sponsor.

NCT NCT00851448
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00851448 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer Patients. A Randomised, Double-blind, Controlled Pilot Study
Lead sponsor
Fresenius Kabi
Phase
Not applicable
Overall status
Terminated
Start date
October 31, 2009
Completion date
April 30, 2011
Enrollment
17 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cachexia, cancer